Skip to content
PubMed This is a summary of 11 peer-reviewed journal articles Updated
Pediatrics

Understanding a Positive Newborn Screen for 3-MCC

At a Glance

A positive newborn screen for 3-MCC means your baby needs further testing to check how they process protein. While most cases are completely benign and asymptomatic, you must feed your baby frequently and never let them fast until the results are confirmed.

Receiving an unexpected call about your baby’s newborn screen is a frightening experience. It is important to take a breath and know that a positive screen is not a final diagnosis. In the case of 3-methylcrotonyl-CoA carboxylase deficiency (often shortened to 3-MCC), a positive screen often leads to a very manageable situation, and many children with this marker never become ill [1][2].

What is 3-MCC Deficiency?

3-MCC is a rare genetic condition that affects how the body processes protein. Specifically, the body has trouble breaking down an amino acid (a building block of protein) called leucine [3][4].

To understand this, imagine your body has a “recycling center” for protein. In most people, a specific enzyme (a protein that speeds up chemical reactions) called 3-MCC acts like a worker on a conveyor belt, processing leucine so the body can turn it into energy [5]. In a baby with 3-MCC deficiency, this worker isn’t there or isn’t working correctly. This causes certain byproducts to build up in the blood and urine [3][6].

Why Most Results Are Reassuring

While the name sounds complex, 3-MCC is unique among metabolic conditions because it is frequently “benign,” meaning it often does not cause health problems [7][8].

  • Asymptomatic Children: The vast majority of infants identified through screening remain asymptomatic (showing no symptoms) throughout their entire lives [9][1].
  • Maternal 3-MCC: Often, a baby’s “positive” screen is actually detecting the condition in the mother, not the baby [9][10]. Because the mother and baby share a blood supply before birth, the mother’s metabolic markers can show up in the baby’s first blood test. In many cases, these mothers never knew they had the condition [9][10].
  • Incidence: 3-MCC is one of the more common conditions found on expanded newborn screens, with rates reported between 1 in 30,000 to 1 in 80,000 births depending on the region [7][1].

What to Do While You Wait for Results

After a positive screen, your doctor will order confirmatory tests (blood and urine analysis). It can take several weeks for these results to come back. During this waiting period, you must treat your baby as if they have the condition.

To keep your baby safe right now:

  1. Feed Frequently: Do not let your baby go long periods without eating. Fasting is the primary trigger for a metabolic crisis. Ask your doctor for the strict maximum hours your baby can go between feeds. You will likely need to wake your baby up at night to feed them.
  2. Watch for Illness: If your baby develops a fever, starts vomiting, or refuses to eat, this is a medical emergency.
  3. Monitor Energy Levels: If your baby is unusually lethargic, extremely difficult to wake up, or feels “floppy,” take them to the nearest emergency room immediately.

Managing Confirmed 3-MCC

If the diagnosis is confirmed, doctors focus on “preventative” care:

  • Illness Protocols: The main risk is metabolic decompensation (a sudden severe illness caused by metabolic stress) [2][11]. Doctors will provide an “emergency letter” dictating exactly what IV fluids the hospital must give your child during a fever or stomach bug [11][8].
  • Carnitine: Some doctors recommend a daily supplement called L-carnitine, which helps the body clear out the toxic byproducts [2][8].

For most families, 3-MCC becomes a “notebook condition”—something you keep in a medical file and mention to doctors during a fever, but which otherwise does not change your child’s ability to grow, play, and thrive [1][2].

Common questions in this guide

What does a positive newborn screen for 3-MCC mean?
A positive screen means your baby's blood showed markers indicating they might have trouble breaking down a specific protein building block called leucine. However, this is not a final diagnosis, and confirmatory blood and urine tests are required.
Is 3-MCC deficiency dangerous for my baby?
For the vast majority of children, 3-MCC is considered benign and they show no symptoms throughout their entire lives. In many cases, the positive screening result is actually detecting asymptomatic 3-MCC in the mother rather than the baby.
What should I do while waiting for the confirmatory 3-MCC test results?
Until the diagnosis is officially ruled out, you must treat your baby as if they have the condition. The most important step is to feed your baby frequently and never let them fast, which often means waking them up during the night for feedings.
What are the warning signs of a metabolic crisis in a baby with 3-MCC?
Seek emergency medical care immediately if your baby develops a fever, starts vomiting, or refuses to eat. Extreme lethargy, difficulty waking up, or feeling physically 'floppy' are also severe warning signs that require urgent hospital evaluation.
How is confirmed 3-MCC deficiency treated?
Treatment primarily relies on preventative care, including strict emergency illness protocols for receiving specific IV fluids during fevers or stomach bugs. Some doctors also prescribe a daily L-carnitine supplement to help the body safely clear out toxic metabolic byproducts.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.While we wait for the final test results, what is the absolute maximum number of hours my baby can go without feeding?
  2. 2.What specific symptoms should prompt me to take my baby to the emergency room immediately?
  3. 3.Should I wake my baby up during the night to feed them?
  4. 4.When exactly should we expect the results of the confirmatory blood and urine tests to come back?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (11)
  1. 1

    Newborn screening for 3-methylcrotonyl-CoA carboxylase deficiency in Zhejiang province, China.

    Cheng Y, Chen P, Yu Z, et al.

    Clinica chimica acta; international journal of clinical chemistry 2023; (542()):117266 doi:10.1016/j.cca.2023.117266.

    PMID: 36822454
  2. 2

    An acute life-threatening episode of rhabdomyolysis, renal failure, altered mental status and hyperammonemia in an adult with 3-methylcrotonyl-CoA carboxylase deficiency.

    McGowan R, Yano S

    Molecular genetics and metabolism reports 2024; (41()):101138 doi:10.1016/j.ymgmr.2024.101138.

    PMID: 39286770
  3. 3

    Biochemical and molecular characterization of 3-Methylcrotonylglycinuria in an Italian asymptomatic girl.

    Cozzolino C, Villani GR, Frisso G, et al.

    Genetics and molecular biology 2018; (41(2)):379-385 doi:10.1590/1678-4685-GMB-2017-0093.

    PMID: 29767664
  4. 4

    Substrate-enhanced filamentation of 3-methylcrotonyl-CoA carboxylase in Legionella pneumophila.

    Somarathne RP, Shrestha R, Zehra M, et al.

    bioRxiv : the preprint server for biology 2025; doi:10.64898/2025.12.22.694428.

    PMID: 41509382
  5. 5

    The cryo-EM structure of trypanosome 3-methylcrotonyl-CoA carboxylase provides mechanistic and dynamic insights into its enzymatic function.

    Plaza-Pegueroles A, Aphasizheva I, Aphasizhev R, et al.

    Structure (London, England : 1993) 2024; (32(7)):930-940.e3 doi:10.1016/j.str.2024.03.010.

    PMID: 38593794
  6. 6

    Newborn screening and genetic diagnosis of 3-methylcrotonyl-CoA carboxylase deficiency in Quanzhou,China.

    Lin W, Wang K, Chen Y, et al.

    Molecular genetics and metabolism reports 2024; (40()):101127 doi:10.1016/j.ymgmr.2024.101127.

    PMID: 39188588
  7. 7

    3-Methylcrotonyl-CoA carboxylase deficiency newborn screening in a population of 536,008: is routine screening necessary?

    Wang H, Liu S, Wang B, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2019; (32(12)):1321-1326.

    PMID: 31730530
  8. 8

    Psychological Impact of Newborn Screening for 3-Methylcrotonyl-CoA Carboxylase Deficiency: The Parental Experience.

    Gragnaniello V, Gaiga G, Cazzorla C, et al.

    International journal of neonatal screening 2025; (11(4)) doi:10.3390/ijns11040115.

    PMID: 41440811
  9. 9

    Primary and maternal 3-methylcrotonyl-CoA carboxylase deficiency: insights from the Israel newborn screening program.

    Rips J, Almashanu S, Mandel H, et al.

    Journal of inherited metabolic disease 2016; (39(2)):211-7 doi:10.1007/s10545-015-9899-4.

    PMID: 26566957
  10. 10

    Maternal Inborn Errors of Metabolism Detected in Expanded Newborn Metabolic Screening.

    Tin O, Zübarioğlu T, Cansever MŞ, et al.

    Turkish archives of pediatrics 2023; (58(4)):382-387 doi:10.5152/TurkArchPediatr.2023.23009.

    PMID: 37317575
  11. 11

    3-methylcrotonyl-CoA carboxylase deficiency in a child with developmental regression and delay: call for early diagnosis and multidisciplinary approach.

    Gulzar MM, Sarani ZA, Tariq M, Knerr I

    BMJ case reports 2025; (18(7)) doi:10.1136/bcr-2024-262865.

    PMID: 40639867

This page is for educational purposes only and does not replace professional medical advice. Always consult your pediatrician or a metabolic specialist immediately regarding your baby's specific newborn screening results and feeding schedules.

Get notified when new evidence is published on 3-methylcrotonyl-CoA carboxylase deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.